Michael E. Kuss

903 total citations
18 papers, 727 citations indexed

About

Michael E. Kuss is a scholar working on Pharmacology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael E. Kuss has authored 18 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael E. Kuss's work include Inflammatory mediators and NSAID effects (9 papers), Anesthesia and Pain Management (7 papers) and Pain Management and Opioid Use (3 papers). Michael E. Kuss is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Anesthesia and Pain Management (7 papers) and Pain Management and Opioid Use (3 papers). Michael E. Kuss collaborates with scholars based in United States, Spain and Germany. Michael E. Kuss's co-authors include Richard C. Hubbard, Shobha Dhadda, Sheela Talwalker, D Lecomte, Aziz Laurent, Stephen Daniels, Michael C. Snabes, Eugene R. Viscusi, Seth Zuckerman and David G. Soergel and has published in prestigious journals such as Gastroenterology, Pain and Anesthesiology.

In The Last Decade

Michael E. Kuss

18 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Kuss United States 12 367 340 201 133 123 18 727
Stephen Daniels United States 17 418 1.1× 390 1.1× 329 1.6× 148 1.1× 136 1.1× 23 988
Craig Kornick United States 11 201 0.5× 119 0.3× 326 1.6× 50 0.4× 175 1.4× 12 844
Nancy Z. Olson United States 17 386 1.1× 349 1.0× 350 1.7× 44 0.3× 38 0.3× 33 895
Patricia B. Embree United States 12 351 1.0× 182 0.5× 677 3.4× 61 0.5× 93 0.8× 27 907
Joachim Osinski United States 11 387 1.1× 40 0.1× 166 0.8× 110 0.8× 168 1.4× 12 860
Candace Bramson United States 15 85 0.2× 317 0.9× 96 0.5× 81 0.6× 69 0.6× 36 823
R.P.F. Scott United States 13 519 1.4× 153 0.5× 749 3.7× 44 0.3× 88 0.7× 29 1.1k
C. W. Hand United Kingdom 15 214 0.6× 106 0.3× 408 2.0× 78 0.6× 124 1.0× 25 897
Ioanna Vasileiou Greece 12 147 0.4× 116 0.3× 76 0.4× 96 0.7× 114 0.9× 29 641
Steen Andersen Denmark 9 123 0.3× 57 0.2× 292 1.5× 105 0.8× 87 0.7× 17 613

Countries citing papers authored by Michael E. Kuss

Since Specialization
Citations

This map shows the geographic impact of Michael E. Kuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kuss more than expected).

Fields of papers citing papers by Michael E. Kuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kuss. The network helps show where Michael E. Kuss may publish in the future.

Co-authorship network of co-authors of Michael E. Kuss

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Kuss. A scholar is included among the top collaborators of Michael E. Kuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Kuss. Michael E. Kuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Viscusi, Eugene R., Lynn R. Webster, Michael E. Kuss, et al.. (2015). A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain. Pain. 157(1). 264–272. 169 indexed citations
4.
Minkowitz, Harold S., et al.. (2013). A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery. Journal of Pain Research. 6. 79–79. 6 indexed citations
5.
Lipsky, Benjamin A., et al.. (2012). Topical Application of a Gentamicin-Collagen Sponge Combined with Systemic Antibiotic Therapy for the Treatment of Diabetic Foot Infections of Moderate Severity. Journal of the American Podiatric Medical Association. 102(3). 223–232. 49 indexed citations
6.
7.
8.
Stoltz, Randall, Stuart Harris, Michael E. Kuss, et al.. (2002). Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. The American Journal of Gastroenterology. 97(1). 65–71. 55 indexed citations
9.
Snabes, Michael C., et al.. (2002). Efficacy and Safety of Intravenous Parecoxib Sodium in Relieving Acute Postoperative Pain following Gynecologic Laparotomy Surgery. Anesthesiology. 97(2). 306–314. 123 indexed citations
10.
Desjardins, Paul J., et al.. (2001). The Injectable Cyclooxygenase-2-Specific Inhibitor Parecoxib Sodium Has Analgesic Efficacy When Administered Preoperatively. Anesthesia & Analgesia. 93(3). 721–727. 110 indexed citations
11.
Wender, Ronald H., et al.. (2001). Parecoxib sodium demonstrates opioid sparing effects in post-laparotomy surgical patients.. Fertility and Sterility. 76(3). S218–S219. 1 indexed citations
12.
Karim, Aziz, et al.. (2001). A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects. The Journal of Clinical Pharmacology. 41(10). 1111–1119. 55 indexed citations
13.
Torri, Sarah, Michael E. Kuss, Sheela Talwalker, S. Daniels, & Michael C. Snabes. (2001). The cyclooxygenase (COX)-2 specific inhibitor valdecoxib effectively treats primary dysmenorrhea.. Fertility and Sterility. 76(3). S95–S95. 3 indexed citations
14.
Noveck, Robert J., Aziz Laurent, Michael E. Kuss, Sheela Talwalker, & Richard C. Hubbard. (2001). Parecoxib Sodium does not Impair Platelet Function in Healthy Elderly and Non-Elderly Individuals. Clinical Drug Investigation. 21(7). 465–476. 71 indexed citations
15.
Hubbard, Richard C., et al.. (2000). An endoscopic study of the gastroduodenal effects of SC-69124A, a parenteral COX-2-specific inhibitor, in the elderly. Gastroenterology. 118(4). A250–A250. 7 indexed citations
16.
Zhao, Sean Z., et al.. (1999). Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee. Clinical Therapeutics. 21(1). 205–217. 11 indexed citations
17.
Rubin, Bernard, F. Gilbert McMahon, David Lee, et al.. (1995). Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee. Clinical Therapeutics. 17(4). 735–745. 24 indexed citations
18.
Vorreuther, R., et al.. (1993). [Gas-forming mycosis of the kidney].. PubMed. 32(1). 53–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Daniels Breakdown of academic impact, for papers by Craig Kornick Breakdown of academic impact, for papers by Nancy Z. Olson Breakdown of academic impact, for papers by Patricia B. Embree Breakdown of academic impact, for papers by Joachim Osinski Breakdown of academic impact, for papers by Candace Bramson Breakdown of academic impact, for papers by R.P.F. Scott Breakdown of academic impact, for papers by C. W. Hand Breakdown of academic impact, for papers by Ioanna Vasileiou Breakdown of academic impact, for papers by Steen Andersen
Rankless by CCL
2026